Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Roberto Castelli, Andrea Zanichelli & Massimo Cugno. (2013) Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic. Immunopharmacology and Immunotoxicology 35:1, pages 181-190.
Read now
Read now
Hilary J Longhurst. (2010) Management of acute attacks of hereditary angioedema: potential role of icatibant. Vascular Health and Risk Management 6, pages 795-802.
Read now
Read now
Lourdes Pastó Cardona, Ramon Lleonart Bellfill & Joaquim Marcoval Caus. (2010) Recent developments in the treatment of acute abdominal and facial attacks of hereditary angioedema: focus on human C1 esterase inhibitor. The Application of Clinical Genetics 3, pages 133-146.
Read now
Read now
Lilian Varga & Henriette Farkas. (2008) Treatment of type I and II hereditary angioedema with Rhucin®, a recombinant human C1 inhibitor. Expert Review of Clinical Immunology 4:6, pages 653-661.
Read now
Read now
Diana Wouters, Ineke Wagenaar-Bos, Marieke van Ham & Sacha Zeerleder. (2008) C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. Expert Opinion on Biological Therapy 8:8, pages 1225-1240.
Read now
Read now
Articles from other publishers (30)
Marcel Levi & Danny M Cohn. (2019) The Role of Complement in Hereditary Angioedema. Transfusion Medicine Reviews 33:4, pages 243-247.
Crossref
Crossref
Marcel Levi, Danny M. Cohn & Sacha Zeerleder. (2019) Hereditary angioedema: Linking complement regulation to the coagulation system. Research and Practice in Thrombosis and Haemostasis 3:1, pages 38-43.
Crossref
Crossref
Ashwag Aloyouny & Eric T. Stoopler. (2016) Vibrational angioedema: considerations for oral health care providers. Special Care in Dentistry 36:6, pages 335-338.
Crossref
Crossref
Daniel Schürmann, Eva Herzog, Elmar Raquet, Marc Nolte, Frauke May, Jochen Müller-Cohrs, Jenny Björkqvist, Gerhard Dickneite & Ingo Pragst. (2017) C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk. Thrombosis and Haemostasis 112:11, pages 960-971.
Crossref
Crossref
Jan Over, Christine Kramer, Anky Koenderman, Diana Wouters & Sacha Zeerleder. 2013. Production of Plasma Proteins for Therapeutic Use. Production of Plasma Proteins for Therapeutic Use
241
258
.
Paloma Campo, Tahía D. Fernandez, Gabriela Canto & Cristobalina Mayorga. (2013) Angioedema induced by angiotensin-converting enzyme inhibitors. Current Opinion in Allergy & Clinical Immunology 13:4, pages 337-344.
Crossref
Crossref
Getaw Worku Hassen, Hossein Kalantari, Monica Parraga, Roger Chirurgi, Carlos Meletiche, Christopher Chan, Jacque Ciarlo, Farhad Gazi, Christopher Lobaito, Siamak Tadayon, Selamawit Yemane & Carolina Velez. (2013) Fresh Frozen Plasma for Progressive and Refractory Angiotensin-Converting Enzyme Inhibitor-induced Angioedema. The Journal of Emergency Medicine 44:4, pages 764-772.
Crossref
Crossref
M. Maurer & L.C. Parish. (2013) The dermatology view of hereditary angio-oedema: practical diagnostic and management considerations. Journal of the European Academy of Dermatology and Venereology 27:2, pages 133-141.
Crossref
Crossref
Anurag Relan, Kamran Bakhtiari, Edwin S. van Amersfoort, Joost C.M. Meijers & C. Erik Hack. (2012) Recombinant C1-Inhibitor. BioDrugs 26:1, pages 43-52.
Crossref
Crossref
M. Cicardi, K. Bork, T. Caballero, T. Craig, H. H. Li, H. Longhurst, A. Reshef & B. Zuraw. (2012) Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 67:2, pages 147-157.
Crossref
Crossref
Marc A. Riedl, David S. Hurewitz, Robyn Levy, Paula J. Busse, David Fitts & Ira Kalfus. (2012) Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Annals of Allergy, Asthma & Immunology 108:1, pages 49-53.
Crossref
Crossref
T. J. Craig, A. K. Bewtra, S. L. Bahna, D. Hurewitz, L. C. Schneider, R. J. Levy, J. N. Moy, J. Offenberger, K. W. Jacobson, W. H. Yang, F. Eidelman, G. Janss, F. R. Packer, M. A. Rojavin, T. Machnig, H.-O. Keinecke & R. L. Wasserman. (2011) C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study. Allergy 66:12, pages 1604-1611.
Crossref
Crossref
Marco Cicardi & Massimo Cugno. 2011. Kinins. Kinins
289
306
.
A. Zanichelli, R. Vacchini, M. Badini, V. Penna & M. Cicardi. (2011) Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients. Allergy 66:2, pages 192-196.
Crossref
Crossref
Richard G. Gower, Paula J. Busse, Emel Aygören-Pürsün, Amin J. Barakat, Teresa Caballero, Mark Davis-Lorton, Henriette Farkas, David S. Hurewitz, Joshua S. Jacobs, Douglas T. Johnston, William Lumry & Marcus Maurer. (2011) Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies. World Allergy Organization Journal 4:2, pages S9-S21.
Crossref
Crossref
Solange Oliveira Rodrigues ValleAlfeu Tavares FrançaRegis A. CamposAnete Sevciovic Grumach. (2011) C1 Esterase Inhibitor (Human) for the Treatment of Acute Hereditary Angioedema. Clinical medicine. Blood disorders 4, pages CMBD.S4090.
Crossref
Crossref
Richard G Gower, Paula J Busse, Emel Aygören-Pürsün, Amin J Barakat, Teresa Caballero, Mark Davis-Lorton, Henriette Farkas, David S Hurewitz, Joshua S Jacobs, Douglas T Johnston, William Lumry & Marcus Maurer. (2011) Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies. World Allergy Organization Journal 4, pages S9-S21.
Crossref
Crossref
Ibolya Czaller, Katalin Molnár, Dorottya Csuka, Lilian Varga & Henriette Farkas. (2011) Successful Outcome Using C1-Inhibitor Concentrate In Acute Pancreatitis Caused By Hereditary Angioedema. Gastroenterology Nursing 34:1, pages 60-63.
Crossref
Crossref
Lilian Varga, George Füst, Dorottya Csuka & Henriette Farkas. (2011) Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema. Molecular Immunology 48:4, pages 572-576.
Crossref
Crossref
Richard L. Wasserman, Robyn J. Levy, Againdra K. Bewtra, David Hurewitz, Timothy J. Craig, Peter C. Kiessling, Heinz-Otto Keinecke & Jonathan A. Bernstein. (2011) Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks. Annals of Allergy, Asthma & Immunology 106:1, pages 62-68.
Crossref
Crossref
Marco Cicardi & Andrea Zanichelli. (2010) Angioedema due to C1 inhibitor deficiency in 2010. Internal and Emergency Medicine 5:6, pages 481-486.
Crossref
Crossref
Timothy J. Craig, Richard L. Wasserman, Robyn J. Levy, Againdra K. Bewtra, Lynda Schneider, Flint Packer, William H. Yang, Heinz-Otto Keinecke & Peter C. Kiessling. (2010) Prospective Study of Rapid Relief Provided by C1 Esterase Inhibitor in Emergency Treatment of Acute Laryngeal Attacks in Hereditary Angioedema. Journal of Clinical Immunology 30:6, pages 823-829.
Crossref
Crossref
Bruce Zuraw, Marco Cicardi, Robyn J. Levy, Jan H. Nuijens, Anurag Relan, Sonja Visscher, Gerald Haase, Leonard Kaufman & C. Erik Hack. (2010) Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. Journal of Allergy and Clinical Immunology 126:4, pages 821-827.e14.
Crossref
Crossref
Inmaculada Martinez-Saguer, Eva Rusicke, Emel Aygören-Pürsün, Christine Heller, Thomas Klingebiel & Wolfhart Kreuz. (2010) Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. American Journal of Obstetrics and Gynecology 203:2, pages 131.e1-131.e7.
Crossref
Crossref
Inmaculada Martinez-Saguer, Eva Rusicke, Emel Aygören-Pürsün, Nils von Hentig, Thomas Klingebiel & Wolfhart Kreuz. (2010) Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study. Transfusion 50:2, pages 354-360.
Crossref
Crossref
Cecilia L. BASIGLIO, Sandra M. ARRIAGA, Fabián PELUSA, Adriana M. ALMARÁ, Jaime KAPITULNIK & Aldo D. MOTTINO. (2010) Complement activation and disease: protective effects of hyperbilirubinaemia. Clinical Science 118:2, pages 99-113.
Crossref
Crossref
Timothy J. Craig, Robyn J. Levy, Richard L. Wasserman, Againdra K. Bewtra, David Hurewitz, Krystyna Obtułowicz, Avner Reshef, Bruce Ritchie, Dumitru Moldovan, Todor Shirov, Vesna Grivcheva-Panovska, Peter C. Kiessling, Heinz-Otto Keinecke & Jonathan A. Bernstein. (2009) Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. Journal of Allergy and Clinical Immunology 124:4, pages 801-808.
Crossref
Crossref
Wolfhart Kreuz, Inmaculada Martinez-Saguer, Emel Aygören-Pürsün, Eva Rusicke, Christine Heller & Thomas Klingebiel. (2009) C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Transfusion 49:9, pages 1987-1995.
Crossref
Crossref
Massimo Cugno, Andrea Zanichelli, Fabrizio Foieni, Sonia Caccia & Marco Cicardi. (2009) C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends in Molecular Medicine 15:2, pages 69-78.
Crossref
Crossref
László Beinrohr, József Dobó, Péter Závodszky & Péter Gál. (2008) C1, MBL–MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation. Trends in Molecular Medicine 14:12, pages 511-521.
Crossref
Crossref